  See all
 |
Articles: Breast |
Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): A phase II randomised trial
The Lancet Oncology - Online First, 02/09/10
Comparison of patient-reported breast, arm, and shoulder symptoms and body image after radiotherapy for early breast cancer: 5-year follow-up in the randomised Standardisation of Breast Radiotherapy (START) trials
The Lancet Oncology - Online First, 02/09/10 Caspase 8 and maspin are downregulated in breast cancer cells due to CpG site promoter methylation
BMC Cancer, 02/09/10
Free full text
Grading system for lymph vessel tumor emboli: significant outcome predictor for patients with invasive ductal carcinoma of the breast who received neoadjuvant therapy
Modern Pathology, 02/09/10 Immunohistochemical surrogate markers of breast cancer molecular classes predicts response to neoadjuvant chemotherapy
Cancer, 02/09/10 Targeting endothelin A receptor enhances anti-proliferative and anti-invasive effects of the HER2 antibody trastuzumab in HER2-overexpressing breast cancer cells
International Journal of Cancer, 02/09/10 
Prior Articles
Recurrence and mortality dynamics for breast cancer patients undergoing mastectomy according to estrogen receptor status: Different mortality but similar recurrence
Cancer Science, 02/08/10 The association between ERCC2 Asp312Asn polymorphism and breast cancer risk: A meta-analysis involving 22,766 subjects
Breast Cancer Research and Treatment, 02/08/10 Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer
Medical Oncology, 02/08/10 Has the role of two functional polymorphisms, R72P in P53 and MDM2-309 in MDM2 in breast cancer become clearer
Breast Cancer Research, 02/08/10
Free full text
Deregulated E2F and the AAA+ Coregulator ANCCA Drive Proto-Oncogene ACTR/AIB1 Overexpression in Breast Cancer
Molecular Cancer Research, 02/08/10 Tumor suppressor function of Rab25 in triple-negative breast cancer
International Journal of Cancer, 02/08/10 Retinoic acid protects human breast cancer cells against etoposide-induced apoptosis by NF-kappaB-dependent but cIAP2-independent mechanisms
Molecular Cancer, 02/08/10
Free full text
Open-label, phase II, multicenter, randomized study of the efficacy and safety of two dose levels of pertuzumab, a human epidermal growth factor receptor 2 dimerization inhibitor, in patients with human epidermal growth factor receptor 2-negative metastatic breast cancer
Journal of Clinical Oncology, 02/05/10 Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women
Journal of Clinical Oncology, 02/05/10 A study of medical intervention in routine breast cancer follow-up
Clinical Oncology, 02/05/10 The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment
Cancer and Metastasis Reviews, 02/05/10 Attitudes of Canadian Radiation Oncologists towards Post-lumpectomy Radiotherapy for Elderly Women with Stage I Hormone-responsive Breast Cancer
Clinical Oncology, 02/05/10 The role of TP53 and p21 gene polymorphisms in breast cancer biology in a well specified and characterized German cohort
Journal of Cancer Research & Clinical Oncology, 02/05/10 Randomized study of lapatinib alone or in combination with trastuzumab in women with ERBB2-positive, trastuzumab-refractory metastatic breast cancer
Journal of Clinical Oncology, 02/04/10
|
|
Receive free subspecialty "5-minute updates" via email
|
|
Indexed Journals: Journal of Clinical Oncology, Cancer Research, Annals Oncology
more...
|
125 Available Pages
|
|
